ASND - Bathi sadurunge bunga, pajak, lan amortisasi Ascendis Pharma AS

Ascendis Pharma A/S is implementing ESG standards to reduce its environmental footprint and ensure compliance with bioethics. The company's EBITDA reflects its cash generation dynamics, where 145.99 determines the current status of the parameter. Business efficiency is based on the outsourcing of clinical trials and distribution. Additionally, the robotization of protein compound synthesis via the TransCon system minimizes laboratory errors.

Ascendis Pharma Inc. - Bathi operasional EBITDA ASND (periode 23.11.2025 - 10.11.2026)

Ringkesan rincian data analitis Ascendis Pharma (ASND)

- kuotasi saiki lan rata-rata prakiraan nilai:

Kutipan saham Ascendis|ASND - Prakiraan konsensus analis

- statistik kapitalisasi pasar:

Nilai pasar Ascendis Pharma|ASND - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Rega Buku Saham Ascendis Pharma|ASND - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku ascendispharma.com|ASND - Total Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

Utang marang Ekuitas Ascendis Pharma A/S|ASND - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Ascendis Pharma AS|ASND - Utang perusahaan|Rasio utang marang kapitalisasi buku Ascendis Pharma|ASND - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Ascendis Pharma|Koefisien jangkoan perantara ascendispharma.com

- rincian asil keuangan lan kelipatan valuasi:

ASND - Bathi resik perusahaan|Bathi mangsa ngarep Ascendis Pharma A/S|ASND - Pangali P/E|Pangali Forward P/E ascendispharma.com|ASND - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Ascendis Pharma|ASND - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Ascendis Pharma|ASND - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan ascendispharma.com|ASND - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Ascendis Pharma A/S

Analisis kabeh metrik perusahaan:Ascendis (ASND)

Produk sing diprodhuksi Ascendis Pharma A/S

The indicator calculates the daily cash flow from operating activities, excluding non-cash accounting adjustments from previous periods. This metric captures real operating income, allowing for the timely detection of declining demand and the avoidance of capital freezes. For Ascendis Pharma A/S (ASND), this reflects the commercialization efficiency of the TransCon platform and the monetization of long-acting drugs. Revenue dynamics directly impact the EBITDA as of the current date. A decline in this line signals fundamental business risks.

Karo sapa Ascendis Pharma A/S saingan